Literature DB >> 24151040

The lungs as anatomical reservoirs of HIV infection.

Cecilia T Costiniuk1, Mohammad-Ali Jenabian.   

Abstract

Failure of antiretroviral therapy to eradicate HIV, even in individuals who suppress the virus to undetectable levels, is a consequence of persistent infection in latently infected cells and within anatomical reservoirs. Support for the notion that the lungs are distinct anatomical reservoirs of HIV comes from a spectrum of studies that have documented different levels of HIV within the lungs compared with the peripheral blood. Different HIV variants have also been found within these two compartments, including variants with distinct antiretroviral resistance mutations. Given that macrophages are long-lived cellular reservoirs of HIV because of their resistance to apoptosis, HIV can persist for prolonged periods within alveolar macrophages that are abundant within the lungs. Furthermore, the large number of cells in close proximity within the lungs provides fertile grounds for cell-to-cell spread of HIV. Distinct immunological pressures in the lungs compared with the peripheral blood likely account for differences in HIV levels within these two compartments in addition to the finding of different variants within these regions. Furthermore, coinfections and tobacco may serve as local stimuli to induce further HIV replication within the lungs. Herein, we review the evidence supporting the notion that lungs are important reservoirs of HIV infection, and we discuss various factors influencing HIV burden within these reservoirs.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 24151040     DOI: 10.1002/rmv.1772

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  29 in total

Review 1.  Tuberculosis and HIV Coinfection.

Authors:  Judith Bruchfeld; Margarida Correia-Neves; Gunilla Källenius
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-26       Impact factor: 6.915

Review 2.  Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment.

Authors:  Jay Rappaport; David J Volsky
Journal:  J Neurovirol       Date:  2015-05-02       Impact factor: 2.643

3.  Brain Microglial Cells Are Highly Susceptible to HIV-1 Infection and Spread.

Authors:  Jennifer J Cenker; Ryan D Stultz; David McDonald
Journal:  AIDS Res Hum Retroviruses       Date:  2017-06-26       Impact factor: 2.205

4.  HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue-Destructive Phenotype.

Authors:  Nancy P Y Chung; Xuemei Ou; K M Faisal Khan; Jacqueline Salit; Robert J Kaner; Ronald G Crystal
Journal:  Cell Rep       Date:  2017-05-09       Impact factor: 9.423

Review 5.  Nanotechnology approaches to eradicating HIV reservoirs.

Authors:  Shijie Cao; Kim A Woodrow
Journal:  Eur J Pharm Biopharm       Date:  2018-06-04       Impact factor: 5.571

6.  Lymphocytic alveolitis is associated with the accumulation of functionally impaired HIV-specific T cells in the lung of antiretroviral therapy-naive subjects.

Authors:  C Preston Neff; Jennifer L Chain; Samantha MaWhinney; Allison K Martin; Derek J Linderman; Sonia C Flores; Thomas B Campbell; Brent E Palmer; Andrew P Fontenot
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

7.  T Cell-Macrophage Fusion Triggers Multinucleated Giant Cell Formation for HIV-1 Spreading.

Authors:  Lucie Bracq; Maorong Xie; Marie Lambelé; Lan-Trang Vu; Julie Matz; Alain Schmitt; Jérôme Delon; Paul Zhou; Clotilde Randriamampita; Jérôme Bouchet; Serge Benichou
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

Review 8.  Macrophages and HIV-1: An Unhealthy Constellation.

Authors:  Quentin J Sattentau; Mario Stevenson
Journal:  Cell Host Microbe       Date:  2016-03-09       Impact factor: 21.023

9.  Early innate and adaptive immune perturbations determine long-term severity of chronic virus and Mycobacterium tuberculosis coinfection.

Authors:  Wenxi Xu; Laura M Snell; Mengdi Guo; Giselle Boukhaled; Bethany L Macleod; Ming Li; Michael V Tullius; Cynthia J Guidos; Ming-Sound Tsao; Maziar Divangahi; Marcus A Horwitz; Jun Liu; David G Brooks
Journal:  Immunity       Date:  2021-01-29       Impact factor: 31.745

10.  The HIV-Tat protein interacts with Sp3 transcription factor and inhibits its binding to a distal site of the sod2 promoter in human pulmonary artery endothelial cells.

Authors:  Terrin L Manes; Ari Simenauer; Jason L Geohring; Juliana Flemming; Michael Brehm; Adela Cota-Gomez
Journal:  Free Radic Biol Med       Date:  2019-12-19       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.